ArticleCancers2024

Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.

Anneke D van Dijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.